loadpatents
name:-0.024736881256104
name:-0.02081298828125
name:-0.0012049674987793
Dufresne; Claude Patent Filings

Dufresne; Claude

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dufresne; Claude.The latest application filed is for "electron microscope and method for transmission electron microscopy imaging of sample arrays".

Company Profile
1.22.21
  • Dufresne; Claude - East Brunswick NJ
  • Dufresne; Claude - Dollard-des-Ormeaux N/A CA
  • Dufresne; Claude - Dollar-des-Ormeaux CA
  • Dufresne, Claude - Dollard des Omeaux CA
  • Dufresne; Claude - Quebec CA
  • Dufresne; Claude - Edison NJ
  • Dufresne; Claude - Lachine CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Electron microscope and method for transmission electron microscopy imaging of sample arrays
Grant 10,199,198 - Dufresne , et al. Fe
2019-02-05
Electron Microscope And Method For Transmission Electron Microscopy Imaging Of Sample Arrays
App 20170207062 - DUFRESNE; Claude ;   et al.
2017-07-20
Fused aromatic PTP-1B inhibitors
Grant 9,334,295 - Colucci , et al. May 10, 2
2016-05-10
Fused Aromatic Ptp-1b Inhibitors
App 20150045325 - Colucci; John ;   et al.
2015-02-12
Fused aromatic PTP-1B inhibitors
Grant 8,927,526 - Colucci , et al. January 6, 2
2015-01-06
Beta carboline sulphonylurea derivatives as EP4 receptor antagonists
Grant 8,685,999 - Berthelette , et al. April 1, 2
2014-04-01
Fused Aromatic Ptp-1b Inhibitors
App 20130281365 - COLUCCI; John ;   et al.
2013-10-24
Fused aromatic PTP-1B inhibitors
Grant 8,481,742 - Colucci , et al. July 9, 2
2013-07-09
Fused Aromatic Ptp-ib Inhibitors
App 20120178679 - COLUCCI; John ;   et al.
2012-07-12
Fused aromatic PTP-1B inhibitors
Grant 8,168,815 - Colucci , et al. May 1, 2
2012-05-01
Beta Carboline Sulphonylurea Derivatives As Ep4 Receptor Antagonists
App 20110275660 - Berthelette; Carl ;   et al.
2011-11-10
Novel Pharmaceutical Compounds
App 20100137371 - Berthelette; Carl ;   et al.
2010-06-03
Fused Aromatic Ptp-1b Inhibitors
App 20100022477 - Colucci; John ;   et al.
2010-01-28
Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors
Grant 7,622,501 - Dufresne , et al. November 24, 2
2009-11-24
Pyridopyrrolizine and pyridoindolizine derivatives
Grant 7,618,979 - Leblanc , et al. November 17, 2
2009-11-17
Method and Apparatus for Automatically Isolating Microbial Species
App 20080318310 - Dufresne; Claude ;   et al.
2008-12-25
Combination Therapy for Treating Cyclooxygenase-2 Mediated Diseases or Conditions in Patients at Risk of Thrombotic Cardiovascular Events
App 20080242722 - Dufresne; Claude ;   et al.
2008-10-02
Nitric Oxide Releasing Prodrugs of Diaryl-2-(5H)-Furanones as Cyclooxygenase-2 Inhibitors
App 20080242643 - Dufresne; Claude ;   et al.
2008-10-02
Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
Grant 7,199,154 - Berthelette , et al. April 3, 2
2007-04-03
Aryldifluoromethylphosphonic acids for treatment of diabetes
Grant 7,163,932 - Dufresne , et al. January 16, 2
2007-01-16
Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
Grant 7,144,913 - Wang , et al. December 5, 2
2006-12-05
Pyridopyrrolizine and pyridoindolizine derivatives
App 20050272756 - Leblanc, Yves ;   et al.
2005-12-08
Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
App 20050261245 - Berthelette, Carl ;   et al.
2005-11-24
Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
App 20040180934 - Wang, Zhaoyin ;   et al.
2004-09-16
Aryldifluoromethylphosphonic acids for treatment of diabetes
App 20040176330 - Dufresne, Claude ;   et al.
2004-09-09
Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates
Grant 6,777,433 - Leblanc , et al. August 17, 2
2004-08-17
Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates
App 20030114703 - Leblanc, Yves ;   et al.
2003-06-19
Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
Grant 6,498,151 - Li , et al. December 24, 2
2002-12-24
Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
App 20020091104 - Li, Chung Sing ;   et al.
2002-07-11
Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
App 20020058644 - Leblanc, Yves ;   et al.
2002-05-16
Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates
App 20020052347 - Leblanc, Yves ;   et al.
2002-05-02
Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase IB (PTP-IB)
App 20020052344 - Leblanc, Yves ;   et al.
2002-05-02
Phosphonic and carboxylic acid derivatives as inhibitors of protein tyrosine phosphatase-1B (PTP-1B)
Grant 6,365,592 - Leblanc , et al. April 2, 2
2002-04-02
Battery charger for cellular phone, having speaker
App 20010006336 - Yi, Sang Yong ;   et al.
2001-07-05
Quinoline leukotriene antagonists
Grant 5,952,347 - Arison , et al. September 14, 1
1999-09-14
Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
Grant 5,472,964 - Young , et al. December 5, 1
1995-12-05
Squalene synthetase inhibitors
Grant 5,132,320 - Bergstrom , et al. July 21, 1
1992-07-21
Process for preparing substituted phenylalkenoic acids
Grant 4,453,005 - Belanger , et al. June 5, 1
1984-06-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed